Signs of multiple sclerosis may surface years before diagnosis, as patients use healthcare more often for early symptoms.

BTK inhibitors such as tolebrutinib or evobrutinib work about as well as Aubagio at preventing relapses in MS, a review of studies found.

Scientists have long suspected that industrial pollutants might help trigger multiple sclerosis, but the latest evidence ...

Specialists in multiple sclerosis will gather in San Diego for ACTRIMS Forum 2026, Feb. 5-7, where the theme will be “MS at a ...

People who are exposed to certain forever chemicals may be at greater risk of developing multiple sclerosis (MS), according to new research. No one knows why that is, but it could help explain why, ...

Multiple sclerosis may quietly damage the brain for years before symptoms appear, and scientists can now see it coming.

A major Murdoch University review has found that for many people with multiple sclerosis (MS), walking is hindered not only ...

Smoking is an established risk factor for multiple sclerosis (MS). Smoking also worsens the course of disease for people who already have MS. MS is an inflammatory disease that involves the breakdown ...

Multiple sclerosis is a disease in which the immune system erroneously attacks a protective insulation that surrounds neurons, known as myelin. As myelin d | Microbiology ...

Molecular imaging is redefining in vivo characterization of multiple sclerosis, a demyelinating disease with complex and heterogeneous clinical profiles. Recent advances in PET tracers enable more ...

People with multiple sclerosis (MS) often face higher unemployment rates. Understanding the challenges and available support can help you navigate employment and financial stability. Many people ...